K58
Conditions
Interventions
Group 1: Intervention group: Participation in the online training “My Irritable Bowel” (dealing with irritable bowel syndrome symptoms with cognitive-behavioral therapy content and nutrition-related c
9 sessions of ca 25 minutes plus individual practice time, 8-week period)
Group 2: Active control group: participation in the “My Relaxation” online training program (progressive muscle relaxation
9 sessions of ca 25 minutes plus individual practice time, 8-week period)
Sponsors
Technische Universität Dresden
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: + Irritable bowel syndrome (at least mild symptom severity) + Access to a device with internet access (computer, mobile phone or tablet) + Sufficient knowledge of the German language + Consent to participate/consent and data protection declaration
Exclusion criteria
Exclusion criteria: × Participation in the previous pilot study on “My Irritable Bowel” (Dec. 2019 to May 2020) × Current psychotherapy treatment × Current suicidal tendencies in the last two weeks × Substance dependence in the last 6 months (alcohol and/or drugs) × Current pregnancy or breastfeeding × Current or previous psychotic illness × Atypical warning symptoms that are likely indicative of an illness other than irritable bowel syndrome (blood in the stool, onset of illness over the age of 50, unexplained severe weight loss, unexplained recurring fever)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At the following points in time: Pre, Mid (+4 weeks), Post (+8 weeks), Follow-Up 1 (+12 weeks), Follow-Up 2 (+24 weeks): symptom severity (IBS-SSS) | — |
Secondary
| Measure | Time frame |
|---|---|
| At the following points in time: Pre, during the training period (only the outcomes marked with *), Mid (+4 weeks), Post (+8 weeks), Follow-Up 1 (+12 weeks), Follow-Up 2 (+24 weeks) • Quality of life (IBS-QOL) • Work and Social Adjustment Scale (ASAS, English: WSAS) • Depression (PHQ-9) • Somatization (PHQ-15) • Anxiety (GAD-7) • Well-being (WHO-5) • Health-related control variables (duration of illness and subtype of irritable bowel syndrome, changes in everyday life, diagnostic findings, medication or treatment, other chronic illnesses and intolerances, other external influences on quality of life, exercise frequency, ROM-IV criteria, health status, disease concept*) • Irritable bowel symptoms (individual query; IBS, GIS) • Irritable bowel-related knowledge and behavior (psychoeducation)* • Irritable bowel-related thoughts* • Stress / relaxation (PSS-10, query on use of PMR*) • Change in eating behavior (how and what you eat)* • Attention redirection* • Change in self-observation and exposure to anxiety* • Socio-demographic variables • Expectations of training participation & intention to use • Therapeutic alliance (adapted WAI-SR, only 1/4 of the questionnaire) • Adherence*, exercise frequency*, training experience*, self-reflection* and training evaluation* All questionnaires that are not followed by a questionnaire abbreviation in brackets are newly created for this study. | — |
Countries
Austria, Germany, Switzerland
Contacts
Public ContactLinda Hilla
Technische Universität Dresden
Outcome results
None listed